News | November 10, 2025
Venus Remedies expands ASEAN presence with new drug approvals in Vietnam
Venus Remedies now has 29 active product approvals in Vietnam alone
Venus Remedies now has 29 active product approvals in Vietnam alone
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
Kygevvi combines two pyrimidine nucleosides, doxecitine and doxribtimine, which act by integrating deoxycytidine and deoxythymidine into skeletal muscle mitochondrial DNA
Performance driven by growth portfolio momentum, pipeline advancements, and strategic business development
The FW500 is designed to meet the evolving needs of mid-sized diagnostic laboratories
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
This approval marks a significant milestone in women’s health, introducing Bayer’s first hormone-free treatment for menopause-related symptoms
Glenmark’s Ropivacaine Hydrochloride Injection USP is bioequivalent and therapeutically equivalent to the reference listed drug Naropin Injection of Fresenius Kabi USA
Updated indication expands treatment options for patients with ulcerative colitis and Crohn’s disease when tumor necrosis factor (TNF) blockers are clinically inadvisable
Subscribe To Our Newsletter & Stay Updated
